U.S. Markets open in 21 hrs, 8 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,288.54 | 73.03 | 0.65% |
| NASDAQ | 2,245.38 | -6.08 | -0.27% |
| S&P 500 | 1,262.90 | 1.38 | 0.11% |
| Day Low 09:30 AM EDT | 49.16 | |
|---|---|---|
| Day High 12:57 PM EDT | 51.00 |
|
| Range | 1.84 | |
| Volume | 11.58 M | |
| 30-Day Avg. Vol. | 9.54 M |
|
| Difference | 21.40% | |
| Market Cap. | 55.34 B | |
| Change | 2.17 B | |
| Shares Out. | 1.08 B | |
| Percent Traded | 1.06% | |
| Revenue | 14.77 B | |
| Earnings | 3.16 B | |
| EPS (TTM) | 2.90 |
| 52-Wk Low 3/20/08 | 39.16 | |
|---|---|---|
| 52-Wk High 10/15/07 | 59.08 |
|
| Range | 19.92 | |
| Prev. Close 7/2/08 | 48.84 | |
| Today's Open | 49.32 | |
| Change | 0.98% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 0.7239 | |
| P/E Ratio (TTM) | 17.41 | |
| P/E Ratio (Fwd.) | — |
Amgen is among the biggest of the biotech big'uns. And it's determined to get even bigger. The company uses cellular biology and medicinal chemistry to target cancers, kidney ailments, inflammatory disorders, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.969 12/31/07 | 1.00 12/31/07 |
0.031
Beat
|
| Last Quarter | 1.046 3/31/08 | 1.12 3/31/08 |
0.074
Beat
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 3.61 B | 14.77 B |
| Gross Profit | 2.99 B | 12.08 B |
| Operating Income | 1.42 B | 5.30 B |
| Net Income | 1.14 B | 3.17 B |
